3-Bromo-4-fluoro-5-nitrobenzoic acid, 95.0%, 250mg

2-Chloro-5,6,8-trimethoxyquinoline, 95%, 500mg

Methyl 2-cyanobenzoate, 99.0%, 10g

4,6-Di-tert-butylbenzene-1,3-diol, 98%, 5g

N,N'-(Pyridine-2,6-diyl)bis(2,2-dimethylpropanamide), 97%, 1g

Ethyl 3,4-dichlorobenzoylformate, 96.0%, 1g

GC capillary column ROTI®Cap-624, 50 m, 0.32 mm, 1.80 µm, 1 Piece(s)

(S)-2-PHENYLPIPERIDINE, 95.0%, 100mg

7,9-Diphenyl-8H-cyclopenta[a]acenaphthylen-8-one>95.0%(HPLC)(qNMR)5g

GC capillary column ROTI®Cap-1, 50 m, 0.32 mm, 0.25 µm, 1 Piece(s)

METHYL (2S)-4-METHYL-2-(METHYLAMINO)PENTANOATE HYDROCHLORIDE, 95%, 250mg

2-Amino-4-fluoro-6-methylphenol, 95.0%, 100mg

tert-Butyl (2R,3S)-(-)-6-oxo-2,3-diphenyl-4-morpholinecarboxylate, 98.0%, 25g